恒瑞医药(01276.HK)10月29日耗资442.77万元回购7万股A股

Core Viewpoint - Heng Rui Medicine (01276.HK) announced a share buyback plan, indicating confidence in its stock value and commitment to returning capital to shareholders [1] Group 1: Buyback Details - The company plans to repurchase 70,000 A shares at a total cost of RMB 4.4277 million [1] - The buyback price per share is set between RMB 62.9 and RMB 63.58 [1]